Seminars in Hematology
Volume 43, Issue 1 , Pages 1-2 , January 2006

Graft-Versus-Host Disease in the 21st Century: New Perspectives on an Old Problem

References 

  1. Brown RA, Adkins D, Khoury H, Vij R, Goodnough LT, Shenoy S, et al. Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients (graft-versus-host disease and transplant-related mortality) . J Clin Oncol . 1999;17:806–812
  2. Storb R , Deeg HJ , Farewell V , Doney K , Appelbaum F , Beatty P , et al.   Marrow transplantation for severe aplastic anemia (methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease) . Blood . 1986;68:119–125
  3. Nash RA , Antin JH , Karanes C , Fay JW , Avalos BR , Yeager AM , et al.   Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors . Blood . 2000;96:2062–2068
  4. Glucksberg H , Storb R , Fefer A , Buckner CD , Neiman PE , Clift RA , et al.   Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors . Transplantation . 1974;18:295–304
  5. Ferrara JL . Cytokine dysregulation as a mechanism of graft versus host disease . Curr Opin Immunol . 1993;5:794–799
  6. Przepiorka D , Weisdorf D , Martin P , Klingemann HG , Beatty P , Hows J , et al.   1994 Consensus Conference on Acute GVHD Grading . Bone Marrow Transplant . 1995;15:825–828

PII: S0037-1963(05)00241-6

doi: 10.1053/j.seminhematol.2005.11.028

Seminars in Hematology
Volume 43, Issue 1 , Pages 1-2 , January 2006

Article Tools